Literature DB >> 19279090

The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Kathryn S Jones1, Ying K Huang, Sébastien A Chevalier, Philippe V Afonso, Cari Petrow-Sadowski, Daniel C Bertolette, Antoine Gessain, Francis W Ruscetti, Renaud Mahieux.   

Abstract

Little is known about the transmission or tropism of the newly discovered human retrovirus, human T-cell lymphotropic virus type 3 (HTLV-3). Here, we examine the entry requirements of HTLV-3 using independently expressed Env proteins. We observed that HTLV-3 surface glycoprotein (SU) binds efficiently to both activated CD4(+) and CD8(+) T cells. This contrasts with both HTLV-1 SU, which primarily binds to activated CD4(+) T cells, and HTLV-2 SU, which primarily binds to activated CD8(+) T cells. Binding studies with heparan sulfate proteoglycans (HSPGs) and neuropilin-1 (NRP-1), two molecules important for HTLV-1 entry, revealed that these molecules also enhance HTLV-3 SU binding. However, unlike HTLV-1 SU, HTLV-3 SU can bind efficiently in the absence of both HSPGs and NRP-1. Studies of entry performed with HTLV-3 Env-pseudotyped viruses together with SU binding studies revealed that, for HTLV-1, glucose transporter 1 (GLUT-1) functions at a postbinding step during HTLV-3 Env-mediated entry. Further studies revealed that HTLV-3 SU binds efficiently to naive CD4(+) T cells, which do not bind either HTLV-1 or HTLV-2 SU and do not express detectable levels of HSPGs, NRP-1, and GLUT-1. These results indicate that the complex of receptor molecules used by HTLV-3 to bind to primary T lymphocytes differs from that of both HTLV-1 and HTLV-2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279090      PMCID: PMC2682092          DOI: 10.1128/JVI.02285-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Molecular characterization and phylogenetic analyses of a new, highly divergent simian T-cell lymphotropic virus type 1 (STLV-1marc1) in Macaca arctoides.

Authors:  R Mahieux; J Pecon-Slattery; A Gessain
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses.

Authors:  J L Battini; J M Heard; O Danos
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor.

Authors:  J M Heard; O Danos
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity.

Authors:  L Delamarre; A R Rosenberg; C Pique; D Pham; M C Dokhélar
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Neurologic consequences of HTLV-II infection in injection-drug users.

Authors:  G Dooneief; R Marlink; K Bell; K Marder; B Renjifo; Y Stern; R Mayeux
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

6.  In vivo infection of human T-cell leukemia virus type I in non-T cells.

Authors:  Y Koyanagi; Y Itoyama; N Nakamura; K Takamatsu; J Kira; T Iwamasa; I Goto; N Yamamoto
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

7.  Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation.

Authors:  S E Macatonia; J K Cruickshank; P Rudge; S C Knight
Journal:  AIDS Res Hum Retroviruses       Date:  1992-09       Impact factor: 2.205

8.  Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay.

Authors:  D Persaud; J L Muñoz; S L Tarsis; E S Parks; W P Parks
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas).

Authors:  P Goubau; M Van Brussel; A M Vandamme; H F Liu; J Desmyter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II).

Authors:  S Ijichi; M B Ramundo; H Takahashi; W W Hall
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Current concepts regarding the HTLV-1 receptor complex.

Authors:  David Ghez; Yves Lepelletier; Kathryn S Jones; Claudine Pique; Olivier Hermine
Journal:  Retrovirology       Date:  2010-11-29       Impact factor: 4.602

Review 2.  Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.

Authors:  Kathryn S Jones; Sophie Lambert; Manuella Bouttier; Laurence Bénit; Frank W Ruscetti; Olivier Hermine; Claudine Pique
Journal:  Viruses       Date:  2011-06-15       Impact factor: 5.048

Review 3.  HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Viruses       Date:  2011-07-08       Impact factor: 5.048

4.  Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.

Authors:  Hiroo Hoshino
Journal:  Front Microbiol       Date:  2012-06-21       Impact factor: 5.640

5.  Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey.

Authors:  David M Sintasath; Nathan D Wolfe; Hao Qiang Zheng; Matthew LeBreton; Martine Peeters; Ubald Tamoufe; Cyrille F Djoko; Joseph L D Diffo; Eitel Mpoudi-Ngole; Walid Heneine; William M Switzer
Journal:  Retrovirology       Date:  2009-10-27       Impact factor: 4.602

Review 6.  HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology.

Authors:  Antoine Gessain; Réjane Rua; Edouard Betsem; Jocelyn Turpin; Renaud Mahieux
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.